B O O K - American College of Rheumatology

ACR/ARHP Poster Session B
1225. Physician Opinion of Variables That Differentiate Disease
Activity and Damage in Systemic Sclerosis. Geneviève Gyger,
Ernest Lo, Marie Hudson, Canadian Scleroderma Research
Group and Murray Baron, McGill, Canada.
1226. Plasma Endogenous Met- and Leu-Enkephalin Levels Are
Decreased and Associated with Clinical and Laboratory
Parameters in Early Systemic Sclerosis. Terry A. McNearney 4 ,
Kathleen A. Sluka 2 , Chul W. Ahn 5 , John D. Reveille 6 , Michael
Fischbach 1 and Maureen D. Mayes 3 , 1 Univ Texas Hlth Sci Ctr
at San Antonio, San Antonio, TX, 2 University of Iowa Medical
Center, Iowa City, IA, 3 University of Texas -Houston Health
Sciences Center, Houston, TX, 4 University of Texas Medical
Branch, Galveston, TX, 5 University of Texas Southwestern
Medical Center, Dallas, TX, 6 University of Texas-Houston Health
Sciences Center, Houston, TX.
1227. Predictors of Interstitial Lung Disease in Early Systemic
Sclerosis: A Prospective Longitudinal Study. Shervin Assassi 2 ,
Roozbeh Sharif 2 , Robert E. Lasky 3 , Terry A. McNearney 1 , Rosa
Estrada Y Martin 3 , Hilda T. Draeger 4 , Deepthi K. Nair 3 , Marvin
J. Fritzler 6 , John D. Reveille 5 , Frank C. Arnett 8 and Maureen D.
Mayes 7 , 1 Eli Lilly and Co, Indianapolis, IN, 2 Univ of Texas Health
Science Houston, Houston, TX, 3 Univ of Texas Health Science
Houston, 4 Univ of Texas Health Science San Antonio, San
Antonio, TX, 5 Univ Texas Health Sci Ctr, Houston, TX, 6 University
of Calgary, Calgary, AB, Canada, 7 University of Texas-Houston,
Houston, TX, 8 UT Medical School, Houston, TX.
1228. Prevalence and Correlates of Sleep Disturbance in Systemic
Sclerosis — Results from the UCLA Scleroderma Quality of Life
Study. Tracy M. Frech 1 , Ron D. Hays 2 , Paul Maranian 3 , Philip J.
Clements 6 , Daniel E. Furst 5 and Dinesh Khanna 4 , 1 Department
of Internal Medicine, University of Utah, Salt Lake City, UT,
2
Division of General Internal Medicine, David Geffen School of
Medicine, Los Angeles, CA, 3 Division of Rheumatology, David
Geffen School of Medicine, Los Angeles, CA, 4 University of
California Los Angeles, Los Angeles, CA, 5 University of California
Los Angeles Medical School, Los Angeles, CA, 6 University of
California Los Angeles School of Medicine, Los Angeles, CA.
1229. Prevalence of Associated Autoimmune Diseases in a Spanish
Population with Systemic Sclerosis. Esther Francisca Vicente 2 ,
María Jesús García-Arias 2 , Rosario García-Vicuña 2 , Alicia
Humbría 2 , Juan Pedro López-Bote 2 and Santos Castañeda 1 ,
1
Rheumatology Department, Hospital Universitario de
La Princesa, IIS Princesa, Madrid, Spain, 2 Rheumatology
Department, Hospital Universitario de La Princesa, IIS Princesa.
1230. Serum Chemokine and Cytokine Levels as Indicators of Disease
Activity in Patients with Systemic Sclerosis. Minoru Hasegawa,
Manabu Fujimoto, Kazuhiko Takehara and Shinichi Sato,
Kanazawa University.
1231. Severe Pulmonary Fibrosis Is Uncommon in Scleroderma
Patients with RNA Polymerase 3 Antibody. Virginia D. Steen 1 ,
Robyn T. Domsic 2 and Thomas Medsger 2 , 1 Georgetown
University, Washington, DC, 2 University of Pittsburgh.
1232. Survival in Pulmonary Hypertension Associated with
Scleroderma-Spectrum Disease: A Single Center Experience.
Dinesh Khanna, Rajeev Saggar, Daniel Furst, Paul Maranian,
Philip Clements and Rajan Saggar, UCLA.
1233. Systemic Sclerosis Is an Independent Predictive Factor to
Coronary Atherosclerosis. Mo Yin Mok, Chak Sing Lau, Sonny
Chiu, Annette Tso, Ka Fung Mak, Woon Sing Wong, Pek Lan
Khong and Karen S. L. Lam, The University of Hong Kong, Queen
Mary Hospital, Hong Kong.
1234. The Psychological Impact of Systemic Sclerosis-Related
Telangiectases. Holly Ennis 3 , Helen L. Richards 1 , Claire Cassidy 3
and Ariane L. Herrick 2 , 1 Mercy University Hospital, Cork, Co.
Cork, Ireland, 2 Rheumatic Diseases Centre, Trust Salford, United
Kingdom, 3 University of Manchester, Manchester, United
Kingdom.
1235. The Use of Calcium-Channel Blockers May Prevent the
Development of Scleroderma Renal Crisis. Gaia Montanelli,
Lorenzo Beretta, Alessandro Santaniello and Raffaella Scorza,
Referral Center for Systemic Autoimmune Diseases.
1236. Time of Transition through Different Patterns of Nailfold
Microangiopathy in Systemic Sclerosis. Alberto Sulli 1 , Carmen
Pizzorni 2 , Francesca Ravera 2 , Elisa Alessandri 2 , Giuseppe
Zampogna 2 , Bruno Seriolo 2 and Maurizio Cutolo 1 , 1 Research
Laboratory and Academic Unit of Clinical Rheumatology,
Department of Internal Medicine, University of Genova,
Genova, Italy, 2 Research Laboratory and Academic Unit of
Clinical Rheumatology, Department of Internal Medicine,
University of Genova, Genova, Italy.
1237. Ultrasonographic Assessment of Hand Joint and Tendon
Involvement in 30 Patients with Systemic Sclerosis. Emmanuel
Chatelus, Hélène Chifflot, Viriginie Clavert, Christelle
Sordet, Jacques-Eric Gottenberg and Jean Sibilia, Hospital of
Hautepierre, Strasbourg, France.
1238. Vaccination Against Influenza in Patients with Scleroderma.
Irena Litinsky 3 , Alexandra Balbir 2 , Devy Zisman 4 , Michal
Mandelboim 1 , Ella Mendelson 1 , Marina Anouk 3 , Ilana Kaufman 3 ,
Daphna Paran 3 and Ori Elkayam 3 , 1 Central Virology Laboratory,
Sheba Medical Center, 2 Department of Rheumatology,
Rambam Health Care Campus Background, 3 Department of
Rheumatology, Tel Aviv Medical Center, 4 Rheumatology Service,
Carmel Medical Center.
1239. Wound Fluid of Skin Ulcers in Systemic Sclerosis: Cellular and
Cytokines’ Profile Helps To Define Healers Versus Non Healers
Characteristics. Stefano Alivernini 1 , Barbara Tolusso 2 , Mariarita
Gigante 2 , Annunziata Capacci 2 , Francesca Faustini 2 , Silvia
Laura Bosello 2 , Maria De Santis 2 and Gianfranco Ferraccioli 1 ,
1
Rheumatology Division, Catholic University of the Sacred Heart,
Rome, Rome, Italy, 2 Rheumatology Division, Catholic University
of the Sacred Heart, Rome, Italy, Italy.
T Cell Biology and Targets in Autoimmune Disease
1240. A Novel Role for the Jak-Stat Pathway in Rheumatoid Arthritis:
Inhibition of TNF-Induced T Cell Attracting Chemokine
Synthesis in Fibroblast-Like Synoviocytes (FLS) by Tasocitinib.
Sanna Rosengren 2 , Gary S. Firestein 2 and David L. Boyle 1 , 1 UCSD
Schl of Medicine, La Jolla, CA, 2 UCSD School of Medicine, La
Jolla, CA.
1241. A Th17 Immune Response Can Be Amplified by Human Th9
Cells. Andreas Ramming 1 , Hendrik Schulze-Koops 2 and Alla
Skapenko 2 , 1 Division of Rheumatology, University of Munich,
Munich, Bavaria, Germany, 2 Division of Rheumatology,
University of Munich, Munich, Germany.
1242. Addition of Retinoic Acid and TGF-beta Accelerate the
Maturation Naive CD8+ Cells into CD8+CD25+FOXP3+
Regulatory Cells. J. Dixon Gray 1 , Stephanie Q. Pan 2 and David
A. Horwitz 1 , 1 University of Southern California, Los Angeles, CA,
2
University of Southern California.
2010 Program Book 225